CHAIRMAN OF THE BOARD
Povl-André has a Masters of Science degree from CBS. He has had long career in the life sciences industry, where he held several commercial and financial leadership positions. He holds a number of board positions, and serves as Chairman of the Board at 2cureX AB, which is listed on the Nasdaq First North Sweden exchange.
Gitte has a degree in market economies and has more than 20 years of leadership experience within life sciences industries, where she has worked in strategic and commercial business development. She has held positions that include CFO, COO and supply chain manager at pharmaceutical companies Meda and Mylan. In connection with these roles, she has participated in several international M&A transactions. She currently holds the CEO position at UV Clinical.
Elsebeth has a university degree in Economics and has held numerous international positions within the life sciences industry. She was international manager at GN Danavox A/S (now GN Resound), director at Coloplast A/S, and CEO of Danish Health Consult A/S. Additionally, she has served as the dean of the Bioanalyst Faculty in Copenhagen and as a mentor at DTU Science Park, DeepTech since 2014.
Peter has an M.Sc. in Electrical, Electronics and Communications Engineering from Danish Technical University. He is currently President and CEO of RTX A/S, a Nasdaq Main Market mid-cap company listed on Nasdaq Nordic that designs and develops wireless communication products across a wide range of applications. Peter has a long career behind him in product and technology development, manufacturing and consumer electronics. Peter has previously held senior positions at Flügger A/S, Grundfos Management A/S and Nokia Corporation.